Multimodal MRI neurodevelopmental profiling in type 1 diabetes: long-term effects of MDI vs CSII treatments
The Journal of Clinical Endocrinology & Metabolism · 15.07.2026 · 111 (8) · 2275-2292
DOI: 10.1210/clinem/dgag102 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 07.03.2026. Verfasst von Pasquale Anthony Della Rosa und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroradiology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan 20132, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Insulin Infusion Systems, Hypoglycemic Agents. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Italian Ministry of Ecological Transition.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
The developing brain is particularly vulnerable to glycemic extremes in early-onset type 1 diabetes (T1D). However, how treatment-specific modalities may influence long-term neurodevelopmental trajectories remains poorly understood.
Objective
To characterize multimodal MRI neurodevelopmental profiles in pediatric T1D and evaluate treatment-related effects of multiple daily injections (MDI) vs continuous subcutaneous insulin infusion (CSII) on brain structure, function, and test whether glycated hemoglobin (HbA1c)-linked imaging features relate to executive–working-memory performance.
Methods
Sixteen children with T1D (8 MDI and 8 CSII from diagnosis) and eight controls underwent structural MRI, diffusion MRI, and resting-state fMRI. Union Recursive Feature Elimination selected gray matter (GM), white matter (WM), and resting-state functional connectivity (rs-FC) features discriminating groups; regression related selected features to long-term age-adjusted mean HbA1c. NEPSY-II Word List Interference (WI) was administered; control-referenced WI outcomes were examined vs HbA1c and HbA1c-associated structural features, including mediation.
Results
Functional features outperformed structural features (balanced accuracy 0.83 vs 0.67). MDI showed reduced GM/WM integrity and disrupted fronto-temporal and subcortical connectivity vs CSII and controls. Right inferior frontal gyrus (IFG) volume correlated with HbA1c (r = 0.71, P < .05) and predicted HbA1c (β = 0.28, P = .015). Higher HbA1c related to poorer WI repetition (r = −0.60, P = .013), and right IFG volume related to poorer WI repetition (r = −0.70, P = .002). Mediation supported an indirect HbA1c effect via right IFG volume (a × b = −0.676; Sobel z = −1.765, one-tailed P = .0388), explaining ∼64% of the total association. CSII had 30% lower hyperglycemia exposure than MDI and higher WI repetition mean ranks (11.19 vs 5.81; P = .023).
Conclusion
Pediatric T1D is associated with multimodal neuroimaging alterations influenced by insulin treatment modality. CSII may confer neuroprotective benefits by improving metabolic control and preserving functional connectivity. Right IFG volume is a candidate imaging marker linking metabolic regulation to interference-sensitive executive–working-memory vulnerability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroradiology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan 20132, Italy.
- Department of Metacognition, "br-ing" Primary and Lower Secondary Bilingual School, Via San Tommaso, snc, Castelvenere, Benevento 82037, Italy.
- Department of Pediatrics, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
- Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan 20133, Italy.
- Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
- Developmental Psychopathology Unit, IRCCS Ospedale San Raffaele, Milan 20132, Italy.
ORCID-Profile: Sonia Francesca Calloni, Matteo Canini
Förderung
- Italian Ministry of Ecological Transition
Zitieren
APA
Della Rosa, P. A., Pecco, N., Calloni, S. F., Canini, M., Oprandi, C., Pavani, D., Grimaldi, G., Veronese, L., Favalli, V., Frontino, G., Gambarini, A., Olivieri, G., Scotti, R., Pontesilli, S., Ogliari, A., Rigamonti, A., Falini, A., Baldoli, C., & Bonfanti, R. (2026). Multimodal MRI neurodevelopmental profiling in type 1 diabetes: long-term effects of MDI vs CSII treatments. The Journal of Clinical Endocrinology & Metabolism, 111(8), 2275-2292. https://doi.org/10.1210/clinem/dgag102
Vancouver
Della Rosa PA, Pecco N, Calloni SF, Canini M, Oprandi C, Pavani D, et al. Multimodal MRI neurodevelopmental profiling in type 1 diabetes: long-term effects of MDI vs CSII treatments. The Journal of Clinical Endocrinology & Metabolism. 2026;111(8):2275-2292. doi:10.1210/clinem/dgag102
BibTeX
@article{DellaRosa2026,
author = {Della Rosa, Pasquale Anthony and Pecco, Nicolò and Calloni, Sonia Francesca and Canini, Matteo and Oprandi, Claudia and Pavani, Deborah and Grimaldi, Graziana and Veronese, Lorenzo and Favalli, Valeria and Frontino, Giulio and Gambarini, Andrea and Olivieri, Gabriele and Scotti, Roberta and Pontesilli, Silvia and Ogliari, Anna and Rigamonti, Andrea and Falini, Andrea and Baldoli, Cristina and Bonfanti, Riccardo},
title = {Multimodal MRI neurodevelopmental profiling in type 1 diabetes: long-term effects of MDI vs CSII treatments},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {8},
pages = {2275--2292},
doi = {10.1210/clinem/dgag102}
}
EUVIMED